These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19331712)

  • 1. In search of the evidentiary foundation of published Canadian economic evaluations (2001-06).
    Tarride JE; Lim ME; Bowen JM; McCarron CE; Blackhouse G; Hopkins R; O'Reilly D; Xie F; Goeree R
    Int J Technol Assess Health Care; 2009 Apr; 25(2):214-21. PubMed ID: 19331712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluations conducted by Canadian health technology assessment agencies: where do we stand?
    Tarride JE; McCarron CE; Lim M; Bowen JM; Blackhouse G; Hopkins R; O'Reilly D; Xie F; Goeree R
    Int J Technol Assess Health Care; 2008; 24(4):437-44. PubMed ID: 18828938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodological assessment of economic evaluations of alcohol treatment: what is missing?
    Barbosa C; Godfrey C; Parrott S
    Alcohol Alcohol; 2010; 45(1):53-63. PubMed ID: 19808943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, execution, interpretation, and reporting of economic evaluation studies in obstetrics.
    Vintzileos AM; Beazoglou T
    Am J Obstet Gynecol; 2004 Oct; 191(4):1070-6. PubMed ID: 15507923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACCP: economic evaluations of clinical pharmacy services: 2001-2005.
    Perez A; Doloresco F; Hoffman JM; Meek PD; Touchette DR; Vermeulen LC; Schumock GT;
    Pharmacotherapy; 2009 Jan; 29(1):128. PubMed ID: 19113803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A guide to economic evaluation: methods for cost-effectiveness analysis of person-level data.
    Hoch JS; Smith MW
    J Trauma Stress; 2006 Dec; 19(6):787-97. PubMed ID: 17195977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Handling uncertainty in economic evaluations of patient level data: a review of the use of Bayesian methods to inform health technology assessments.
    McCarron CE; Pullenayegum EM; Marshall DA; Goeree R; Tarride JE
    Int J Technol Assess Health Care; 2009 Oct; 25(4):546-54. PubMed ID: 19845985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation for ophthalmologists.
    Kuper H; Jofre-Bonet M; Gilbert C
    Ophthalmic Epidemiol; 2006 Dec; 13(6):393-401. PubMed ID: 17169853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches for economic evaluations of health care technologies.
    Tarride JE; Blackhouse G; Bischof M; McCarron EC; Lim M; Ferrusi IL; Xie F; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):307-16. PubMed ID: 19394571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluations in pain management: principles and methods.
    Asche CV; Seal B; Jackson KC; Oderda GM
    J Pain Palliat Care Pharmacother; 2006; 20(3):15-23. PubMed ID: 16931474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura.
    Xie F; Blackhouse G; Assasi N; Campbell K; Levin M; Bowen J; Tarride JE; Pi D; Goeree R
    Clin Ther; 2009 May; 31(5):1082-91; discussion 1066-8. PubMed ID: 19539109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of nursing practices: a review of literature.
    Lämås K; Willman A; Lindholm L; Jacobsson C
    Int Nurs Rev; 2009 Mar; 56(1):13-20. PubMed ID: 19239511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality appraisal of pediatric health economic evaluations.
    Ungar WJ; Santos MT
    Int J Technol Assess Health Care; 2005; 21(2):203-10. PubMed ID: 15921060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for health technologies: specific guidance for oncology products in Canada.
    Mittmann N; Evans WK; Rocchi A; Longo CJ; Au HJ; Husereau D; Leighl NB; Isogai PK; Krahn MD; Peacock S; Marshall D; Coyle D; Taylor SC; Jacobs P; Oh PI
    Value Health; 2012 May; 15(3):580-5. PubMed ID: 22583470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision-analytical modelling in health-care economic evaluations.
    Sun X; Faunce T
    Eur J Health Econ; 2008 Nov; 9(4):313-23. PubMed ID: 17943332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study Group.
    Nicholson A; Berger K; Bohn R; Carcao M; Fischer K; Gringeri A; Hoots K; Mantovani L; Schramm W; van Hout BA; Willan AR; Feldman BM
    Haemophilia; 2008 Jan; 14(1):127-32. PubMed ID: 18005148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes research and modeling therapeutic interventions for economic evaluations.
    Langley PC
    Clin Ther; 1994; 16(3):538-52. PubMed ID: 7923319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A literature review of assumptions on test characteristics and adherence in economic evaluations of colonoscopy and CT-colonography screening.
    van Gils P; van den Berg M; van Kranen H; de Wit AG
    Eur J Cancer; 2009 Jun; 45(9):1554-9. PubMed ID: 19261464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disproportion of economic impact, research achievements and research support in digestive diseases in Canada.
    Beck IT
    Clin Invest Med; 2001 Feb; 24(1):12-36. PubMed ID: 11266029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.